B₂ receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Behavioural Brain Research

• Publication date

  2015-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbr.2014.10.040PMID 25446751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory muscle pain is dependent on the activation of kinin B1 and B2 receptors and intracellular kinase pathways

  2012cited by this paper
• Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Folic Acid Plus α-Tocopherol Mitigates Amyloid-β-Induced Neurotoxicity through Modulation of Mitochondrial Complexes Activity

  2011cited by this paper
• Local neuroinflammation and the progression of Alzheimer’s disease

  2011cited by this paper
• The selective and competitive N-methyl-D-aspartate receptor antagonist, (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid, prevents synaptic toxicity induced by amyloid-β in mice.

  2011cited by this paper
• Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo.

  2011cited by this paper
• Kallikrein-Kinin System Mediated Inflammation in Alzheimers Disease In Vivo

  2011cited by this paper
• Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease

  2010cited by this paper
• The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide.

  2010cited by this paper
• Role of kinin B1 and B2 receptors in memory consolidation during the aging process of mice.

  2010cited by this paper
• Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice.

  2010cited by this paper
• Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide.

  2009cited by this paper
• Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.

  2008cited by this paper
• Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.

  2008cited by this paper
• Increases of kinin B1 and B2 receptors binding sites after brain infusion of amyloid-beta 1-40 peptide in rats.

  2008cited by this paper
• Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein

  2007cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Role of inflammation in neurodegenerative diseases

  2005cited by this paper
• Kinin B1 receptors: key G‐protein‐coupled receptors and their role in inflammatory and painful processes

  2004cited by this paper
• Deciphering the molecular basis of memory failure in Alzheimer's disease.

  2004cited by this paper
• Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation

  2003cited by this paper
• Expression and function of bradykinin receptors in microglia.

  2003cited by this paper
• Bradykinin receptor modulation in cellular models of aging and Alzheimer's disease.

  2002cited by this paper
• The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease

  2002cited by this paper
• Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes

  2001cited by this paper
• Kinins in pain and inflammation

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).

  1999cited by this paper
• The B1 receptors for kinins.

  1998cited by this paper
• The differences shown by C57BL/6 and DBA/2 inbred mice in detecting spatial novelty are subserved by a different hippocampal and parietal cortex interplay.

  1996cited by this paper
• Increased Inositol 1,4,5‐Trisphosphate Accumulation Correlates with an Up‐Regulation of Bradykinin Receptors in Alzheimer's Disease

  1995cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Intracerebroventricular injections in mice. Some methodological refinements.

  1986cited by this paper
• Pharmacology of bradykinin and related kinins.

  1980cited by this paper

• Role of Kinin B2 Receptor Signaling in Astrocyte-driven Neuroinflammation

  2026cites this paper
• Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases

  2025cites this paper
• JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

  2023cites this paper
• β-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer's disease

  2023cites this paper
• Uso dos antagonistas dos receptores de bradicinina na doença de Alzheimer

  2022influential citation
• The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease

  2022cites this paper
• Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies

  2021cites this paper
• Amyloid β oligomer selective antibodies for Alzheimer’s therapeutics and diagnostics

  2021cites this paper
• Effects of rivastigmine hydrogen tartrate and donepezil hydrochloride on the cognitive function and mental behavior of patients with Alzheimer's disease.

  2020cites this paper
• Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice

  2019cites this paper
• The Dual Role of Kinin/Kinin Receptors System in Alzheimer’s Disease

  2019cites this paper
• NEUROPEPTIDES AND OLIGOPEPTIDASES IN SCHIZOPHRENIA.

  2019cites this paper
• Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.

  2019cites this paper
• A novel crosslinking protocol stabilizes amyloid β oligomers capable of inducing Alzheimer's‐associated pathologies

  2019cites this paper
• fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis

  2019influential citation
• Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer's disease.

  2019cites this paper
• Neuroprotective effects of a potent bradykinin B2 receptor antagonist HOE-140 on microvascular permeability, blood flow disturbances, edema formation, cell injury and nitric oxide synthase upregulation following trauma to the spinal cord.

  2019cites this paper
• El populismo: de intruso a problema relevante para la ciencia social

  2018cites this paper
• Nicotinic Acetylcholine Receptor Signaling: Roles in Neuroprotection

  2018cites this paper
• Association of cerebrovascular dysfunction with the development of Alzheimer’s disease-like pathology in OXYS rats

  2018cites this paper
• Involvement of the Bradykinin B1 Receptor in Microglial Activation: In Vitro and In Vivo Studies

  2017cites this paper
• Acer okamotoanum improves cognition and memory function in Aβ25–35-induced Alzheimer’s mice model

  2017cites this paper
• Inhibitory effect of donepezil on bradykinin-induced increase in the intracellular calcium concentration in cultured cortical astrocytes.

  2017cites this paper
• Targeting JNK for the diagnosis and treatment of Alzheimer's disease

  2017cites this paper
• Blockade of hippocampal bradykinin B1 receptors improves spatial learning and memory deficits in middle‐aged rats

  2017cites this paper
• Differential effect of intranasally administrated kinin B1 and B2 receptor antagonists in Alzheimer’s disease mice

  2016cites this paper
• A participação do receptor TRPA1 na toxicidade induzida por oligômeros de beta-amilóide em diferentes modelos experimentais: um potencial novo alvo para a doença de Alzheimer

  2016cites this paper
• Copper, differently from zinc, affects the conformation, oligomerization state and activity of bradykinin.

  2016cites this paper
• Targeting neuroinflammation in Alzheimer’s disease

  2016cites this paper
• Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease.

  2015cites this paper